Back to DE D. E. Shaw & Co., Inc.

FULCFULC
Showing 8 of 20 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in FULCRUM THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 3M shares of FULC (FULCRUM THERAPEUTICS INC), worth $11.1M as of 2026-Q2. The position was increased (+87.5% shares). FULC represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$11.1M

Current Shares

3M

Total Value Change

+$8.4M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3M
+87.5%
$11.1M0.0%$3.66
43
2026-Q1
Decreased
1.6M
-15.2%
$12.5M0.0%$7.87
0
2025-Q4
Increased
1.9M
+32.0%
$21.6M0.0%$11.34
36
2025-Q3
Increased
1.4M
+23.2%
$13.3M0.0%$8.67
34
2025-Q2
Increased
1.2M
+102.7%
$8.1M0.0%$7.10
44
2025-Q1
Decreased
580,661
-0.4%
$1.7M0.0%$3.01
0
2024-Q4
Decreased
583,203
-23.0%
$2.7M0.0%$4.68
0
2024-Q3
Increased
757,731
+28.0%
$2.7M0.0%$3.77
33

Other major holders of FULC: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used